Milk and plasma pharmacokinetics of single‐dose ubrogepant in healthy lactating women
Less than 0.02 mg of a 100 mg dose of ubrogepant was excreted in breast milk over a 24-h period. The minimal transfer of ubrogepant into breast milk is not considered clinically relevant.
Authors
- Eric Cohen (ORCID: https://orcid.org/0000-0001-9205-090X)
- Ramesh Boinpally (ORCID: https://orcid.org/0000-0001-8267-9210)
- Joel M. Trugman (ORCID: https://orcid.org/0000-0002-2376-8878)
- Jonathan Smith (ORCID: https://orcid.org/0000-0001-8300-4426)
Institutions
- AbbVie (United States) (US)
Publication Details
- Journal
- Headache The Journal of Head and Face Pain
- Published
- 2025-05-20
- DOI
- https://doi.org/10.1111/head.14960
- Citations
- 4
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.88
Funders
- AbbVie